LOGIN  |  REGISTER

Recent Insider Transactions - Sarepta Therapeutics (NASDAQ: SRPT)

Follow NASDAQ:SRPT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/08/2024
Buy
$13.90
15,000
$209K
37,840
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/08/2024
Sell
$123.85
3,155
$391K
34,685
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/08/2024
Sell
$123.10
11,745
$1.446M
22,940
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/08/2024
Sell
$122.39
100
$12K
22,840
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/08/2024
Sell
$13.90
15,000
$209K
0
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/07/2024
Sell
$120.49
506
$61K
25,694
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/08/2024
Sell
$123.14
472
$58K
25,222
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/07/2024
Sell
$120.49
512
$62K
68,982
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/08/2024
Sell
$123.14
909
$112K
68,073
NASDAQ SRPT Sarepta Therapeutics
Boor Kathryn Jean / director
03/11/2024
Sell
$122.93
761
$94K
7,516
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/07/2024
Sell
$120.49
506
$61K
29,587
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/08/2024
Sell
$123.14
899
$111K
28,688
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/07/2024
Sell
$120.49
526
$63K
37,199
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/08/2024
Sell
$123.14
1,035
$127K
36,164
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/04/2024
Sell
$125.32
1,389
$174K
37,725
NASDAQ SRPT Sarepta Therapeutics
Mayo Stephen / director
03/05/2024
Sell
$122.96
3,135
$385K
6,621
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/04/2024
Sell
$125.32
1,734
$217K
30,093
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/04/2024
Sell
$125.32
285
$36K
26,437
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/04/2024
Sell
$125.32
237
$30K
26,200
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/04/2024
Sell
$125.32
1,728
$217K
69,494
NASDAQ SRPT Sarepta Therapeutics
Nicaise Claude / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Mayo Stephen / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/01/2024
Sell
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/01/2024
Sell
$128.58
1,543
$198K
27,293
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/01/2024
Sell
$129.71
457
$59K
26,836
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/01/2024
Sell
$126.19
114
$14K
26,722
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/01/2024
Sell
$126.19
251
$32K
22,836
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/01/2024
Sell
$128.67
12,500
$1.608M
12,500
NASDAQ SRPT Sarepta Therapeutics
BEHRENS M KATHLEEN / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Boor Kathryn Jean / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/01/2024
Sell
$128.30
1,200
$154K
39,114
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/01/2024
Sell
$126.19
365
$46K
34,314
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/01/2024
Sell
$128.67
12,500
$1.608M
12,500
NASDAQ SRPT Sarepta Therapeutics
Barry Richard / director
03/01/2024
Buy
$128.67
3,679
$473K
3,679
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/01/2024
Sell
$125.34
2,000
$251K
31,827
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/01/2024
Sell
$126.19
269
$34K
27,827
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
03/01/2024
Sell
$128.67
12,500
$1.608M
12,500
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/01/2024
Sell
$126.19
778
$98K
65,222
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/01/2024
Buy
$128.67
12,500
$1.608M
12,500
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
12/01/2023
Sell
$80.34
3,682
$296K
22,886
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
11/17/2023
Sell
$82.98
4,508
$374K
65,751
NASDAQ SRPT Sarepta Therapeutics
Barry Richard / director
11/03/2023
Buy
$78.81
40,000
$3.152M
140,000
NASDAQ SRPT Sarepta Therapeutics
Barry Richard / director
11/03/2023
Buy
$78.81
10,000
$788K
10,000
NASDAQ SRPT Sarepta Therapeutics
INGRAM DOUGLAS S / director, officer: President & CEO
11/03/2023
Buy
$81.26
200
$16K
390,307
NASDAQ SRPT Sarepta Therapeutics
INGRAM DOUGLAS S / director, officer: President & CEO
11/03/2023
Buy
$80.33
3,884
$312K
390,107
NASDAQ SRPT Sarepta Therapeutics
INGRAM DOUGLAS S / director, officer: President & CEO
11/03/2023
Buy
$79.70
11,060
$881K
386,223
NASDAQ SRPT Sarepta Therapeutics
INGRAM DOUGLAS S / director, officer: President & CEO
11/03/2023
Buy
$78.57
10,081
$792K
375,163
NASDAQ SRPT Sarepta Therapeutics
BEHRENS M KATHLEEN / director
11/03/2023
Buy
$29.03
15,000
$435K
174,993
NASDAQ SRPT Sarepta Therapeutics
BEHRENS M KATHLEEN / director
11/03/2023
Sell
$29.03
15,000
$435K
0
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/14/2023
Buy
$109.89
4,032
$443K
246,996
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/14/2023
Buy
$109.19
5,947
$649K
242,964
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/11/2023
Buy
$108.05
23,686
$2.559M
237,017
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/10/2023
Buy
$106.26
31,570
$3.355M
213,331
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/10/2023
Buy
$105.90
1,091
$116K
181,761
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
08/10/2023
Buy
$104.67
2,206
$231K
180,670
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
08/04/2023
Buy
$29.03
15,000
$435K
35,994
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
08/04/2023
Sell
$106.72
15,000
$1.601M
20,994
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
08/04/2023
Sell
$29.03
15,000
$435K
0
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: EVP, General Counsel
06/01/2023
Sell
$123.60
89
$11K
28,096
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/30/2023
Sell
$136.66
307
$42K
26,367
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/08/2023
Sell
$153.19
912
$140K
70,170
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/08/2023
Sell
$153.19
744
$114K
34,679
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: SVP, General Counsel
03/08/2023
Sell
$153.19
635
$97K
28,185
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/08/2023
Sell
$153.19
314
$48K
26,674
NASDAQ SRPT Sarepta Therapeutics
Wigzell Hans Lennart Rudolf / director
03/06/2023
Buy
$155.99
3,257
$508K
3,257
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/06/2023
Buy
$155.99
27,000
$4.212M
27,000
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/06/2023
Sell
$157.21
186
$29K
22,642
NASDAQ SRPT Sarepta Therapeutics
Arif Bilal / officer: Chief Tech Ops Officer
03/06/2023
Sell
$157.21
154
$24K
22,488
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/06/2023
Sell
$157.21
1,370
$215K
30,923
NASDAQ SRPT Sarepta Therapeutics
Estepan Ian Michael / officer: Chief Financial Officer
03/06/2023
Buy
$155.99
27,000
$4.212M
27,000
NASDAQ SRPT Sarepta Therapeutics
BEHRENS M KATHLEEN / director
03/06/2023
Buy
$155.99
3,257
$508K
3,257
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/06/2023
Sell
$157.21
1,134
$178K
66,582
NASDAQ SRPT Sarepta Therapeutics
Rodino-Klapac Louise / officer: Head of R&D, CSO
03/06/2023
Buy
$155.99
27,000
$4.212M
27,000
NASDAQ SRPT Sarepta Therapeutics
Barry Richard / director
03/06/2023
Buy
$155.99
3,257
$508K
3,257
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: SVP, General Counsel
03/06/2023
Buy
$155.99
27,000
$4.212M
27,000
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: SVP, General Counsel
03/06/2023
Sell
$157.21
1,154
$181K
24,491
NASDAQ SRPT Sarepta Therapeutics
Brown Ryan Edward / officer: SVP, General Counsel
03/06/2023
Sell
$157.21
171
$27K
24,320
NASDAQ SRPT Sarepta Therapeutics
Chambers Michael Andrew / director
03/06/2023
Buy
$155.99
3,257
$508K
3,257

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous